SEARCH 
COMPANIES
Discover the reality of companies and brands!
Find by
name
:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
by
country
:
United States
,
Great Britain
,
Canada
,
Australia
[
+
]
by
top manager
:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
The world's
largest companies
by
thema
, in 2008 [previous month +] :
Restructuring and labor conditions
[
+
],
Human rights and money laundering
[
+
]
Pollution
[
+
]
Financial delinquency
[
+
],
more frequent offshore locations
,
best paid top managers
[
+
]
Influence:corruption/lobby
[
+
]
Information: dubious practice
[
+
]
TRANSNATIONALE.ORG
Free and independant information on large corporations
Why use this site?
How to use it?
Contact us
-
Support this project
King Pharmaceuticals Inc.
Headquarters :
501 Fifth Street Bristol, TN 37620
United States of America
web
www.kingpharm.com
tel.
423-989-8000
stock :
KG
analytics
Brands
name
click to compare prices
Altace
,
AtroPen
,
Avinza
Bicillin
ComboPen
,
Cytomel
EpiPen
Intal
King Pharmaceuticals
Levoxyl
Skelaxin
,
Sonata
,
Synercid
Thrombin-JMI
» Shop local, ethical and at the best price on
Ethishop
« Ethical » rating of King Pharmaceuticals Inc. , group
and subsidiaries
Offshore
2
Sales
2
Bn $.€ /year
Wage
55
*min.
Influence
1
[click on the rating for the method or on the number for the data]
Shareholders (5)
Business & market
Subsidiaries (1)
Locations & production
shareholder
country
%
source
Barclays Plc
6,32
BlackRock Financial Management Inc.
3,27
Lord Abbett & Co
7,45
State Street Corp.
3,22
Vanguard Group Inc.
4,74
»
More shareholders
of King Pharmaceuticals Inc.
subsidiary
country
%
source
Alpharma Inc
100
Les Echos
»
More subsidiaries
of King Pharmaceuticals Inc.
Executives
Labor conditions (1)
Environmental impact
Human impact
year
employees
<>
social impact : country
source
2007
2050
»
More restructuring
at King Pharmaceuticals Inc.
»
Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
1
informations, access to subscribers
»
More restructuring
at King Pharmaceuticals Inc.
»
Layoff plans and labour conditions in 2007
Financials (3)
Lobbying & corruption
Subsidy
Advertising & marketing
year
 
sales
income
source
2007
2,14
0,18
 
billion US$
2006
1,99
0,29
 
billion US$
2005
1,77
0,12
 
billion US$
»
More financial data
for King Pharmaceuticals Inc.
»
Financial delinquency in 2007
year
financial misdemeanor
sales
income
assets
buyback
source
3
informations, access to subscribers
»
More financial data
for King Pharmaceuticals Inc.
»
Financial delinquency in 2007
translate this page in
arabic
chinese
dutch
german
japanese
korean
russian
Legal notice
© T&C 1999-2010
CONTRIBUTIONS